# The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022, Regulation 19: Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004


(1) The Medicines for Human Use (Clinical Trials) Regulations 2004 are amended as follows.
(2) In Schedule 2—
(a) in paragraph 3 for sub-paragraph (5)(b)(iii)(cc) substitute—
“(cc) an integrated care board.”.
(b) in paragraph 6, in sub-paragraph (6)(a)(ii) for “the governing body of a clinical commissioning group” substitute “an integrated care board”.

---
Source: https://www.legislation.gov.uk/uksi/2022/634/regulation/19 (the official version)
Page: https://openlegislation.uk/health-and-care-act-2022-consequential-and-related-amendments-and-transitional-provisions-regulations-2022/regulation-19
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

